The murine acquired immunodeficiency syndrome (MAIDS) caused by defective LP-BM5 murine leukemia virus (MuLV) is a disease that shows severe immunodeficiency with abnormal lymphoproliferation, and hypergammaglobulinemia in susceptible C57BL/6 (B6) mice. To examine the cellular mechanisms of development of MAIDS, we injected LP-BM5 MuLV intraperitoneaUy into B6 mice bearing the X chromosome-linked immunodefidency (xid). xid mice lack functionally mature B cells including Ly-1 B cells (also known as B-1 cells). All B6 mice died by 20 wk after LP-BM5 MuLV inoculation. In marked contrast, xid mice have continued to survive without any sign of MAIDS-related symptoms till at least 20 wk after the inoculation. The delayed progression of MAIDS in x/d mice appears to depend on xid mutation, according to our experiments using both sexes of (B6.xid x B6)F1 and (B6 x B6.xid)F1 mice. Furthermore, Ly-1 B cells, enriched by a FACS | were shown to integrate the defective genome and appeared to be a major virus-infected B cell population. Our data corroborate that Ly-1 B cells play an important role in the induction and progression of MAIDS.
T he murine acquired immunodeficiency syndrome (MAIDS) 1 caused by a defective retrovirus (defective LP-BM5 murine leukemia virus [MuLV]) (1, 2), which encodes a gag fusion protein (Pr60S~s), is a disease that shows many similarities with human AIDS, in particular abnormal lymphoproliferation, polyclonal B cell activation, and severe immunodeficiency (3, 4) . Previous studies have proven that complex cellular interactions between T and B cells are required for the induction and development of MAIDS. B cell abnormalities are shown in the presence of T cells of CD4 phenotype (5) , whereas B cells are required for induction of phenotypic and functional T cell abnormalities in MAIDS (6) . It is interesting that a recent study reported that the majority of cells infected with the defective LP-BM5 MuLV 1 Abbrrviations used in this paper: MAIDS, murine acquired immunodeficiency syndrome; MuLV, murine leukemia virus; xid, X-linked immunodeficiency.
belongs to B cell lineages (7, 8) , implying that B cells trigger the induction and development of MAIDS. The development of hypergammaglobulinemia in MAIDS also suggests that B cell activation and its differentiation is associated with the induction of MAIDS.
It still remains obscure, however, what kinds orB cell subsets are required for and involved in the induction and development of MAIDS. To examine these problems, we used the X-linked immunodeficient (xic 0 mice (9) (10) (11) (12) . The defects in x/d mice, which show the impaired humoral immune response to type II T cell independent antigens (9, 10, 12) , has been implicated in the arrest of functional maturation of B cells. In particular, the lack of Ly-1 B cells (also known as B-1 cells [13] ) is noticed in xid mice (11) .
Here we report that xid mice are resistant to MAIDS and Ly-1 B cells are a major virus-infected B cell population. Our data corroborate that Ly-1 B cells play an important role in the development of retrovirus-induced immunodeficiency, MAIDS. Detection of the Defective LP-BM5 MuLV Genome by PCR. Template DNAs extracted from spleen cells (10 s) of the mice at 7 wk after the virus inoculation were amplified by PCR as described previously (15) . The PCR primers were 5'-CCTCTTCCTTTA-TCGACACT-3' and 5'-ATTAG~GGAATAGCTCG-3'. These primers correspond to the sequences located in the defective LP-BM5 MuLV gag-encoded gene, p15 and p12, respectively. Template DNAs were added to a cocktail adjusted to final concentrations of 10 mM Tris-HC1 (pH 8.3), 50 mM KC1, 1.5 mM MgC12, 0.01% gelatin, 200 #M deoxynucleoside triphosphate, 100 pM of each primer, and 2 U of Taq DNA polymerase (Boehringer Mannheim, Mannheim, Germany) in a total volume of 100/~1, and were subjected to 30 cycles of amplification. In each cycle of PCR, the mixture was denatured at 95~ for 1 rain (5 rain for the first cyde), annealed at 55~ for 3 min, and extended at 72~ for 1 min on a programmed temperature control system (Astec, Fukuoka, Japan). The PCR products (237 bp) were then analyzed by Southern blot hybridization with an internal probe, 5'-TGTCAAAGGGACC-AGTTAAG-3'. The PCR can detect one infected cell among 104-105 cells. As control, DNA from mouse Ib5 receptor (IL-5R) tx chain was amplified by PCR in the same methods. The primers used for PCR reaction were 5'-AAACCTTCGAATGAAACCA-3' and 5'-TGGTATTAAAGGCGAGCTC-3', and define fragments of 216 bp. These primers correspond to the sequences located in the cytoplasmic domain and 3'-uncoding region of IL,5R c~ chain, respectively (16) .
Abs and Reagents. The following monoclonal Abs (mAbs)
were used: RA3-6B2 mAb (rat IgG2a), which recognizes B220 (American Type Culture Collection, Ikockville, MD); 53-7.3 mAb (rat IgG2a), which recognizes Ly-1 (American Type Culture Collection); 2.4G2 mAb (rat IgG1), which recognizes murine FcylL (American Type Culture Collection). Each mAb was purified from ascitic fluids with protein G-column (Pharmacia-LKB Laboratories, Uppsala, Sweden). PE-labded streptavidin (PE-av) was purchased from Becton Dickinson & Co. (Mountain View, CA).
Staining and Sorting of Ly-1 +B220 § Cells. Cells from inguinal
LNs of B6 mice at 14 wk after the LP-BM5 MuLV inoculation were stained with biotinylated anti-Ly-1 mAb plus PE-av and FITC-hbded anti-B220 mAb (RA3-6B2). The stained cells were analyzed by a FACStar | (Becton Dickinson & Co.) and fractionated into Ly-l-B220-, Ly-l+B220 -, Ly-1-B220 +, Ly-1 +-B200 + and unseparated. The cells (104) of sorted fractions were investigated for the detection of defective LP-BM5 MuLV genome and DNA from IbSK ce chain as described above.
Results
C57BL/6 (B6) mice are highly susceptible to LP-BM5 MuLV (this represents a mixture of the replication-defective virus and the ecotropic helper virus) and develop MAIDS in several weeks after viral infection (17, 18) . We injected LP-BM5 MuLV intraperitoneally into B6 mice or B6 mice bearing the X chromosome-linked imm~odefidency (B6.x/d). symptoms. These results further supported the notion that xid mutation is responsible for the delayed progression of MAIDS.
We then investigated the integration of the defective LP-BM5 MuLV genome in spleen cells ( Table 1 MuLV inoculation, whereas the P C R product was clearly shown in the other groups of mice. Since the defective LP-BM5 MuLV has proven to be the disease (MAIDS)-causing virus, it is conceivable that mice bearing the xid mutation are resistant to the defective virus infection. Several B6.xid mice showed splenomegaly and lymphadenopathy 30 wk after the virus inoculation (Fig. 1) . These mice showed the integration of the defective LP-BM5 MuLV genome in cells of the enlarged spleen (data not shown). In addition, we could detect a weak expression of the defective LP-BM5 MuLV genome without remarkable MAIDS-related symptoms 20 wk after virus inoculation in B6.xid mice tested (data not shown).
An apparent correlation between the xid mutation and re- (Fig. 3 c) . These results indicated that Ly-1 B cells were infected with the defective LP-BM5 MuLV.
Discussion
We clearly demonstrated that B6.xid mice did not show any signs of MAIDS-associated symptoms 20 wk after the LP-BM5 MuLV infection, although B6 mice show the symptoms within 7 wk after the MuLV infection at the latest. The defective LP-BM5 MuLV was not detected using PCR and Southern blot hybridization in B6.xid mice 7 wk after inoculation. These results suggest that xid mutation affects the induction and development of MAIDS. In addition, the cell sorting experiments suggest that Ly-1 B cells are the target cell population for the defective LP-BM5 MuLV. In light of our finding, we can hypothesize that Ly-1 B cells play an important role in the induction and progression of MAIDS and the lack of Ly-1 B cells in B6.xid mice may account for the delayed progression of LP-BM5 MuLV infection in xid mice.
Ly-1 B cells, which are characterized by the expression of surface markers such as Ly-1 +, slgMb~g h', slgD aun, B220 dull, and Mac-l+, constitute a distinct B cell lineage and differ in their functional properties from conventional B cells (11, 19) . Huang reported that the majority of the LP-BM5 MuLVinfected cells are B220 aun positive, not B220b~g ht cells (8) . Their B220 a~l cells may be Ly-1 B cells. And it has been reported that all B-lineage cells established in culture from LP-BM5 MuLV-infected mice are Ly-l-positive (20) , and these cells show the expression of multiple copies of the defective virus (21) . These reports may support our data that Ly-1 B cells are target cells for the defective LP-BM5 MuLV.
Several characteristics of Ly-1 B cells could contribute to the development of MAIDS. First, we notice that Ly-1 B cells have a self-renewal ability (22) . Huang et al. (8, 23) reported the induction of MAIDS using a helper-free stock of the def~-tire virus that cannot replicate on its own. The expansion of target ceUs should be necessary for the development of MAIDS in their system. Cheung et al. (24) reported that the levels of transcripts encoded by ecotropic LP-BM5 MuLV (helper virus) were lower than those of defective LP-BM5 MuLV. Their findings also suggest that cell populations expressing defective LP-BM5 MuLV may be amplified, in part, by ceU division, as well as by continuing infection of naive cells. The virus-infected Ly-1 B cells could expand themselves and develop MAIDS. Second, O'Garra et al. (25) reported that Ly-1 B calls are the main source of B cell-derived IL-10, which suppresses cytokine production by Thl-type CD4 + T ceUs and macrophages (26, 27) and has B cell stimulatory activity (28) . In fact, Gazzinelli et al. (29) It is interesting that B6.xid mice had a few Ly-1 B sister cells (known as B-lb cells [13] ) that share several functional features of Ly-1 B cells such as surface phenotypes, an unusual IgM/IgD ratio, certain specificities to antigen, and distinctive anatomical localization, though we do not show the data. These cells in xid mice may play the same role as for Ly-1 + B cells in normal mice, but because of their low frequency, the progression of MAIDS is delayed. It was reported that macrophages from mice with MAIDS express viral RNA coded by ecotropic and defective LP-BM5 MuLV (31) . Our experiments indicated that Ly-l-B220-cells were other target cells of LP-BM5 MuLV. These cell populations may include macrophages. The development of MAIDS in x/d mice, though delayed, may be induced by the virus-infected macrophages. Recent studies demonstrated the presence of transplantable T-lymphoid cells, which integrated the defective viral genome, in C57BL/6 mice infected with LP-BM5 MuLV (4, 32) . These cells may also be involved in the development of MAIDS. But we could not detect the defective virus in the Ly-1 +B220-cell population, which corresponds to T lymphoid cells (Fig. 3) . This discrepancy raises the possibilities that the transplantable T-lymphoid cells may be Ly-1-cells or the frequency of the T-lymphoid cells infected with the defective virus may be too low, i.e., below 1/10,000, to detect the virus genome from Ly-l+B220 -cells.
Failure to exhibit disease in xid mice was due to a block in virus replication (Fig. 2) . The inability to exhibit integration of the defective genome in disease raises the possibility that there may have been a block to spread of helper virus and impaired helper restriction may contribute to the drayed In condusion, we provide evidence in the present study that Ly-1 B cells are required for the progression of MAIDS, although the involvement of Ly-1 B cells may not be sufhcient. The ceUular mechanisms for the induction of a mouse retrovirus-induced immunodeficiency have not been fully covered and need further investigation, our findings would provide a clue to approach this important issue and help in ducidating the pathogenesis of retrovirus-induced immunodefidency syndromes including AIDS.
We thank Miss Ai Kariyone for her excellent technical assistance in operating FACStar | We also thank Drs. Fumiya Imamura and Satoshi Takaki for helpful suggestions throughout this study. We are also indebted to Dr. E. L. Barsoumian for his critical reading of this manuscript.
